Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire
✍ Scribed by Honore A. Meda; Felix Doua; Claude Laveissière; Tanoh W. Miezan; Els Gaens; Kari Brattegaard; Aimé de Muynck; Kevin M. De Cock
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 657 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Few studies have been conducted in developing countries to estimate the prevalence of hepatitis C virus (HCV) infection and its association with human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs). We have screened for hepatitis B virus (HBV) and HCV markers 200 HIV-1 -
Uganda offers a unique setting in which to study the effect of human immunodeficiency virus-1 (HIV-1) on cancer. HIV-1 is prevalent there, and cancers which are known to be HIV-associated, such as Kaposi's sarcoma and Burkitt's lymphoma, are endemic. Adults residing in Kampala, Uganda, presenting wi
## Abstract The effect of the evolving HIV epidemic on cancer has been sparsely documented in Africa. We report results on the risk of cancer associated with HIV‐1 infection using data from an ongoing study. A case–control analysis was used to estimate the relative risk (odds ratio, OR) of cancer t
## Abstract The effect of highly active antiretroviral therapy (HAART) on hepatitis C virus (HCV) infection remains uncertain. This report describes the case of a man with hemophilia with HIV–HCV coinfection with persistent disappearance of HCV RNA after changing the HAART regimen. He had been trea